Cargando…

Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort

BACKGROUND: Proton Pump Inhibitors (PPIs) have been associated with chronic kidney disease (CKD). Our objective was to quantify the association between PPI use and incident CKD in a population-based cohort. METHODS AND FINDINGS: We used a population-based retrospective cohort, including people aged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Poncelas, Antonio, Barceló, Maria A., Saez, Marc, Coll-de-Tuero, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192564/ https://www.ncbi.nlm.nih.gov/pubmed/30332411 http://dx.doi.org/10.1371/journal.pone.0204231

Ejemplares similares

The dynamic behaviour of metabolic syndrome and its components in an eight-year population-based cohort from the Mediterranean
por: Barceló, Maria A., et al.
Publicado: (2017)

What is the optimal cut-off threshold in self-home blood pressure measurement?: A cohort study according to STROBE statement
por: Coll-de-Tuero, Gabriel, et al.
Publicado: (2019)

Effects of the Financial Crisis on Psychotropic Drug Consumption in a Cohort from a Semi-Urban Region in Catalonia, Spain
por: Barceló, Maria A., et al.
Publicado: (2016)

Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area
por: Coll-de-Tuero, Gabriel, et al.
Publicado: (2012)

Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2014)

Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes
por: Rodríguez-Poncelas, Antonio, et al.
Publicado: (2016)

Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2013)

Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2015)

Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy
por: DiGiovanni, Ernest L., et al.
Publicado: (2016)

Regular proton pump inhibitor use and incident dementia: population-based cohort study
por: Zhang, Peidong, et al.
Publicado: (2022)

Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study
por: Rodríguez-Poncelas, Antonio, et al.
Publicado: (2019)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
por: Arora, Pradeep, et al.
Publicado: (2016)

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017)

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
por: Hughes, John, et al.
Publicado: (2018)

Proton Pump Inhibitors and Kidney Disease—GI Upset for the Nephrologist?
por: Toth-Manikowski, Stephanie M., et al.
Publicado: (2017)

Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
por: dos Santos, Andrêza Soares, et al.
Publicado: (2023)

Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007)

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies
por: Wu, Chieh-Chen, et al.
Publicado: (2023)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Estimates of Chronic Kidney Diseases Associated with Proton-Pump Inhibitors Using a Retrospective Hospital-Based Cohort in Thailand
por: Pannoi, Tanavij, et al.
Publicado: (2022)

Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review
por: Edinoff, Amber N., et al.
Publicado: (2023)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
por: de Jong, Hilda J I, et al.
Publicado: (2013)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Pharmacoeconomic Analysis of Fixed-Dose Combinations of Proton Pump Inhibitors Available in India
por: Deolekar, Pradnya, et al.
Publicado: (2023)

Effectiveness of proton pump inhibitor in unexplained chronic cough
por: Park, Hye Jung, et al.
Publicado: (2017)

The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study
por: Douwes, Rianne M., et al.
Publicado: (2020)

Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement
por: Paz, Marco A., et al.
Publicado: (2016)

The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
por: Flothow, Dominik J. G., et al.
Publicado: (2020)

Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children
por: Li, Yanqin, et al.
Publicado: (2020)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bc4v79n06e8cmi82t7ci9st50b